Inactive Instrument

Genetron Holdings Limited

Equities

GTH

US37186H2094

Biotechnology & Medical Research

Genetron Holdings Limited Reiterates Full Year 2021 Revenue Guidance

January 10, 2022 at 04:30 pm IST

Genetron Holdings Limited reiterated its full year 2021 revenue guidance. The Company expects full year 2021 revenue to be around RMB 530 million, representing approximately 25% growth over the Company's full year 2020 revenue.

Latest news about Genetron Holdings Limited

Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index	29/03	CI
New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited	28/03	CI
ADRs End Lower; Saverone 2014 Ltd. Declines 17.7%	13/23/13	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	12/23/12	MT
Sector Update: Health Care	12/23/12	MT
North American Morning Briefing : Hopes A Mild Inflation Print Will Keep Fed on Hold	12/23/12	DJ
Genetron Holdings Signs Merger Agreement to Go Private; Shares Soar Premarket	12/23/12	MT
Genetron Holdings Signs Merger Agreement to Go Private	12/23/12	MT
New Genetron Holding Limited agreed to acquire Genetron Holdings Limited for $130 million.	11/23/11	CI
Genetron Gets Nasdaq Notification Regarding Minimum Bid Price Requirement	24/23/24	MT
Genetron Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	13/23/13	CI
American Depositary Receipts of Asian Stocks Lower Amid Banking Sector Worries	27/23/27	MT
Genetron Holdings Regains Compliance With Nasdaq's Listing Rule	18/23/18	MT
Earlier US Stock Market Losses Weighed on Asian Equities	28/22/28	MT
Genetron Holdings Receives Non-Compliance Notice from Nasdaq	07/22/07	MT
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Reports Q2 Loss $-0.38	12/22/12	MT
Genetron Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12	CI
Asian ADRs Decline in Monday Trading	26/22/26	MT
Genetron Holdings Limited(NasdaqGM:GTH) dropped from S&P Global BMI Index	19/22/19	CI
Sector Update: Health Care Stocks Decline Premarket Monday	22/22/22	MT
Genetron Gets Non-Binding Takeover Offer from CEO	22/22/22	MT
Sizhen Wang made a non binding proposal to acquire the remaining 49.2% stake in Genetron Holdings Limited from Genetron Health (Hong Kong) Company Limited and others for $60 million.	22/22/22	CI
Genetron Holdings Limited Provides Revenue Guidance for the Year 2022	02/22/02	CI
Transcript : Genetron Holdings Limited, Q1 2022 Earnings Call, Jun 02, 2022	02/22/02
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Posts Q1 Revenue $17.40M	02/22/02	MT

Chart Genetron Holdings Limited

Duration

Period

More charts

Company Profile

Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Sector

Biotechnology & Medical Research

Calendar

08/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+48.64%	56.65B
IQVIA HOLDINGS INC.	-6.44%	39.44B
LONZA GROUP AG	+38.31%	39.03B
ICON PUBLIC LIMITED COMPANY	+14.28%	26.75B
CELLTRION, INC.	-11.17%	26.86B
ALNYLAM PHARMACEUTICALS, INC.	-21.40%	19.03B
UNITED THERAPEUTICS CORPORATION	+25.64%	12.26B
BIO-TECHNE CORPORATION	+0.96%	12.28B
MEDPACE HOLDINGS, INC.	+27.04%	12.04B

Other Biotechnology & Medical Research